Price target upside
Denali Therapeutics Price Target Upside or Downside
DNLI price target upside based on the current price and analyst average.
Direct answer
Denali Therapeutics's analyst target implies +42%.
The average target is $34.31 compared with a recorded current price of $24.17.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $24.17
- Average price target
- $34.31
- High price target
- $42.00
- Low price target
- $25.00
- Target upside
- +42%
- Consensus rating
- Strong Buy
- Analysts
- 16
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026